At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
Imaging diagnostic and biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of Non-invasive Magnetic Resonance Imaging Diagnostic Method for Nonalcoholic Steatohepatitis(NASH)
In Brief
A clinical study evaluating Imaging diagnostic and biopsy for Nonalcoholic Steatohepatitis. Completed, enrolled 47 participants across 1 site.
Detailed Summary
1. To evaluate feasibility of using multiparametric Magnetic resonance(MR) imaging to predict nonalcoholic steatohepatitis(NASH) 2. To develop non-invasive diagnosis tool using multiparametric Magnetic resonance(MR) imaging for nonalcoholic steatohepatitis(NASH)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNonalcoholic Steatohepatitis
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedDec 2017
Primary CompletionAug 2018
TodayJul 2026
First PostedDec 15, 2017
Enrollment StartSep 8, 2016
Primary CompletionAug 7, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.5 years ago
Interventions
Imaging diagnostic and biopsyother
Liver biopsy and MRI scan